NOF EUROPE
   

Lipidure®


Back ground

The chemical 2-methacryroyloxyethylphosphorylcholine (MPC) is a groundbreaking, new biocompatible material. NOF became the first company in the world to build a commercial plant capable of producing MPC in forms ranging from monomers to polymers. Because MPC has similar properties to those of cell membranes and contains a polymer substrate, it is highly affinitive to living organs and tissues. This makes it ideal for a wide range of applications, including use in eyecare products such as contact lenses and contact lens solutions, as well as in cosmetics and medical devices. The LipidureŽ CM series is developed as coating solutions for improving the biocompatibility of medical devices.



 

Lipidure®-Coat Plate

Lipidure®-Coat Plate is a cell culture plate for the formation of embryoid body (EB). You can easily obtain EB by dispensing dispersed embryonic stem (ES) cells.
 

Lipidure®-Coat Dish

Lipidure®-Coat Dish is a cell culture dish for the formation of human embryoid body (hEB). You can easily obtain hEB by transplanting human embryonic stem (hES) cells onto feeder...
 

Lipidure®-CM

-Features- -Hemo-compatibility -Anti-adhesion of proteins and cells -Anti-denaturing of proteins -Anti-activation of cells -Usage-
 

Lipidure®-BG

-Features- -Easy to form -Safe/Biocompatible -Can store proteins and drugs -High transparency -pH- and thermo-sensitivity -Water soluble
 









What's New
DDS

2010/07/26 Program for Liposome Conference in Vancouver, Aug 4-8, 2010
PDF

2010/07/08 NOF presents at Liposome Conference in Vancouver, Aug 4-8, 2010

2010/06/30
NOF release New Activated PEG

2010/05/21 NOF AMERICA CORPORATION opened a new office in California

On May 7, NOF AMERICA CORPORATION, a wholly owned subsidiary of NOF,
opened a new office in California to further enhance its sales
activities in the North American market
Post Address: 2102 Business Center Drive, Suite 130 Irvine, CA 92612, USA

2010/03/11 NOF partners with ENZON on PEG derivatives PDF

2010/01/07 NOF signs Exclusive Licensing Agreement on Novel Carrier for Gene Delivery PDF